Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes

Breast Cancer Research and Treatment

Volumn 152, Issue 1, 2015, Pages 183-191

  Liu, Yan ^a,b   Cai, Qiuyin ^a,b   Bao, Ping Ping ^c   Su, Yinghao ^a,b   Cai, Hui ^a,b   Wu, Jie ^a,b   Ye, Fei ^d   Guo, Xingyi ^a,b   Zheng, Wei ^a,b   Zheng, Ying ^c   Shu, Xiao Ou ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Disease free survival; miRNA; Overall survival; TNBC

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; MICRORNA; MICRORNA 126 3P; MICRORNA 218 5P; MICRORNA 27B 3P; MICRORNA 374B 5P; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MRNA EXPRESSION ASSAY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; TRIPLE NEGATIVE BREAST CANCER; CANCER GRADING; CANCER STAGING; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; TREATMENT OUTCOME; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE;

ADULT; AGED; CELL LINE, TUMOR; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; ROC CURVE; TREATMENT OUTCOME; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84931009923     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-015-3460-x     Document Type: Article

References (29)

1. Ossovskaya V, Wang Y, Budoff A et al (2011) Exploring molecular pathways of triple-negative breast cancer. Genes Cancer 2:870–879. doi:10.1177/1947601911432496
2. Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res Off J Am Assoc Cancer Res 13:4429–4434. doi:10.1158/1078-0432.CCR-06-3045
3. Lim LP, Lau NC, Garrett-Engele P et al (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769–773. doi:10.1038/nature03315
4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297. doi:10.1016/S0092-8674(04)00045-5
5. Kumar MS, Lu J, Mercer KL et al (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39:673–677. doi:10.1038/ng2003
6. Iorio MV, Ferracin M, Liu C-G et al (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065–7070. doi:10.1158/0008-5472.CAN-05-1783
7. Calin GA, Ferracin M, Cimmino A et al (2005) A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793–1801. doi:10.1056/NEJMoa050995
8. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866. doi:10.1038/nrc1997
9. Yu S-L, Chen H-Y, Chang G-C et al (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13:48–57. doi:10.1016/j.ccr.2007.12.008
10. Cai J, Guan H, Fang L et al (2013) MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. J Clin Invest 123:566–579. doi:10.1172/JCI65871
11. Cascione L, Gasparini P, Lovat F et al (2013) Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer. PLoS One 8:e55910. doi:10.1371/journal.pone.0055910
12. Png KJ, Halberg N, Yoshida M, Tavazoie SF (2012) A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481:190–194. doi:10.1038/nature10661
13. Tavazoie SF, Alarcón C, Oskarsson T et al (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147–152. doi:10.1038/nature06487
14. Volinia S, Galasso M, Sana ME et al (2012) Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci 109:3024–3029. doi:10.1073/pnas.1200010109
15. Zhang Y, Yang P, Sun T et al (2013) miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol 15:284–294. doi:10.1038/ncb2690
16. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682–688. doi:10.1038/nature06174
17. Jin L, Wessely O, Marcusson EG et al (2013) Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/Neu, EGF, and TNF-α in breast cancer. Cancer Res 73:2884–2896. doi:10.1158/0008-5472.CAN-12-2162
18. Gasparini P, Cascione L, Fassan M et al (2014) MicroRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget 5:1174–1184
19. Shu XO, Zheng Y, Cai H et al (2009) Soy food intake and breast cancer survival. JAMA 302:2437–2443. doi:10.1001/jama.2009.1783
20. Su Y, Zheng Y, Zheng W et al (2011) Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC Cancer 11:292. doi:10.1186/1471-2407-11-292
21. Geiss GK, Bumgarner RE, Birditt B et al (2008) Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26:317–325. doi:10.1038/nbt1385
22. Waggott D, Chu K, Yin S et al (2012) NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data. Bioinforma Oxf Engl 28:1546–1548. doi:10.1093/bioinformatics/bts188
23. Parker JS, Mullins M, Cheang MCU et al (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol Off J Am Soc Clin Oncol 27:1160–1167. doi:10.1200/JCO.2008.18.1370
24. Guo C, Sah FJ, Beard L et al (2008) The non-coding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-Kinase signaling and is frequently lost in colon cancers. Genes Chromosom Cancer 47:939–946. doi:10.1002/gcc.20596
25. Feng R, Chen X, Yu Y et al (2010) miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298:50–63. doi:10.1016/j.canlet.2010.06.004
26. Zhu N, Zhang D, Xie H et al (2011) Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. Mol Cell Biochem 351:157–164. doi:10.1007/s11010-011-0723-7
27. Hebbard LW, Maurer J, Miller A et al (2010) Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo. Cancer Res 70:8863–8873. doi:10.1158/0008-5472.CAN-10-1295
28. Dallol A, Silva NFD, Viacava P et al (2002) SLIT2, a human homologue of the drosophila slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 62:5874–5880
29. Png KJ, Yoshida M, Zhang XH-F et al (2011) MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 25:226–231. doi:10.1101/gad.1974211